ERBB4 as a therapeutic target in aortic dissection: Implications for cell-based therapies in vascular regeneration
Authors:
Open Access
- 14 March 2025
- journal article
- Published by Association of Basic Medical Sciences of FBIH in Biomolecules and Biomedicine
- Vol. 25 (10) , 2324-2334
Abstract
This study investigates the role of Erb-B2 receptor tyrosine kinase 4 (ERBB4) in aortic dissection (AD) pathogenesis and its potential as a therapeutic target in cell-based therapies. Using immunohistochemical (IHC) staining, we examined the phenotypic transition of vascular smooth muscle cells (VSMCs) in thoracic aortic tissue from AD patients. RNA sequencing identified differentially expressed genes (DEGs), highlighting ERBB4 as a key regulator. In vitro, ERBB4 knockdown in human aortic smooth muscle cells (HASMCs) was assessed using cell counting kit-8 (CCK-8 assays), wound healing, transwell migration, colony formation, flow cytometry, and tube formation assays. Our results showed significant inhibition of cell viability, migration, proliferation, and angiogenesis. In vivo, ERBB4 knockdown reduced inflammatory cell infiltration and enhanced collagen fiber contractility, as demonstrated by Masson staining. Mechanistically, ERBB4 silencing suppressed integrin-binding proteins (CD151, ITGAE, ITGB5) and inhibited NF-κB signaling (p-IκBα, p-NF-κB-65). These findings suggest that ERBB4 is critical in AD progression and that its knockdown mitigates pathological changes in HASMCs, reduces inflammation, and restores collagen contractility. ERBB4 may serve as a promising target for cell-based therapies aimed at restoring vascular integrity and function, providing potential new treatment strategies for AD patients.Keywords
This publication has 30 references indexed in Scilit:
- Cysteine-rich protein 2 alters p130Cas localization and inhibits vascular smooth muscle cell migrationCardiovascular Research, 2013
- Smooth muscle cell phenotypic switching in atherosclerosisCardiovascular Research, 2012
- Arterial injury promotes medial chondrogenesis in Sm22 knockout miceCardiovascular Research, 2010
- Smooth Muscle Cells in Atherosclerosis Originate From the Local Vessel Wall and Not Circulating Progenitor Cells in ApoE Knockout MiceArteriosclerosis, Thrombosis, and Vascular Biology, 2006
- The role of neuregulin–ErbB4 interactions on the proliferation and organization of cells in the subventricular zoneProceedings of the National Academy of Sciences, 2006
- Cytoprotective Role of Ca 2+ - Activated K + Channels in the Cardiac Inner Mitochondrial MembraneScience, 2002
- Diagnosis and management of aortic dissection Task Force on Aortic Dissection, European Society of CardiologyEuropean Heart Journal, 2001
- Untangling the ErbB signalling networkNature Reviews Molecular Cell Biology, 2001
- Isolation and characterization of an abundant and novel 22-kDa protein (SM22) from chicken gizzard smooth muscle.Journal of Biological Chemistry, 1987
- Smooth muscle phenotypic modulation: Role in atherogenesisMedical Hypotheses, 1981